Feedback / Questions
AFNT-111 - Affini-T Therap, Erasca
https://www.businesswire.com/news/home/20230303005078/en/Affini-T-Therapeutics-to-Present-Data-from-Lead-Oncogenic-Driver-Candidate-at-AACR-Special-Conference-Targeting-RAS
Mar 3, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next